LGALS9 and neoplasm: Given the increase in tumor-infiltrating neutrophils with TEPA treatment, we examined ligand-receptor expression occurring between this cluster and other subtypes and found this was largely driven by the Galectin-9 (Lgals9) and TNF (Tnf) axes which are known to support CD8+ cytotoxic T and NK cell-mediated cytotoxicity (Supp.